SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.480
-0.070 (-4.52%)
At close: Mar 28, 2025, 4:00 PM
1.516
+0.036 (2.45%)
Pre-market: Mar 31, 2025, 8:08 AM EDT
SAB Biotherapeutics Employees
SAB Biotherapeutics had 57 employees as of December 31, 2023. The number of employees increased by 1 or 1.79% compared to the previous year.
Employees
57
Change (1Y)
1
Growth (1Y)
1.79%
Revenue / Employee
$26,539
Profits / Employee
-$799,428
Market Cap
13.66M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 57 | 1 | 1.79% |
| Dec 31, 2022 | 56 | -83 | -59.71% |
| Dec 31, 2021 | 139 | 53 | 61.63% |
| Dec 31, 2020 | 86 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SABS News
- 2 months ago - SAB BIO to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Why Is SAB BIO Stock Trading Lower On Tuesday? - Benzinga
- 2 months ago - SAB BIO Announces Positive Topline Phase 1 Clinical Results with Potentially Disease-Modifying T1D Therapy SAB-142 - GlobeNewsWire
- 2 months ago - SAB BIO Announces R&D Webinar Event to Review Phase 1 Topline Results for SAB-142, a Disease-Modifying T1D Therapy - GlobeNewsWire
- 5 months ago - SAB BIO Announces Third Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 7 months ago - SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 7 months ago - SAB BIO to Present at the European Association for the Study of Diabetes 60th Annual Meeting - GlobeNewsWire
- 8 months ago - SAB BIO Announces Second Quarter 2024 Financial Results and Provides Company Updates - GlobeNewsWire